Research suggests that Ginkgo Biloba may offer some benefit for anxiety relief, particularly within the context of neurological and stress-related symptoms, though the available evidence reviewed here is limited in scope. The sole study in this set is a 2022 narrative literature review that surveyed existing clinical trial evidence for a range of medicinal herbs — including ginkgo — as supportive approaches for post-COVID-19 symptoms such as anxiety and cognitive decline. While the review's conclusions are generally favorable toward phytotherapy, it is important to note that a narrative review reflects the authors' interpretation of prior research rather than generating new experimental findings, which limits how strongly its conclusions can be applied. Readers should be aware that this evidence base is preliminary, and a broader set of controlled trials focused specifically on Ginkgo Biloba and anxiety would be needed to draw more definitive conclusions.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Medicinal Herbs in the Relief of Neurological, Cardiovascular, and Respirator... | Review | 2022 | Supports | 72 |